100 Pre-Market Indicator
is down -.39 to 3,795.35. The total Pre-Market volume is currently
4,720,433 shares traded.
The following are the
most active stocks for the pre-market session
Achillion Pharmaceuticals, Inc. (
) is +1.48 at $5.73, with 2,855,359 shares traded. As reported in
the last short interest update the days to cover for ACHN is
14.588378; this calculation is based on the average trading volume
of the stock.
Nokia Corporation (
) is +0.02 at $7.92, with 1,172,000 shares traded. NOK's current
last sale is 109.24% of the target price of $7.25.
Apple Inc. (
) is +0.23 at $93.93, with 373,597 shares traded. Over the last
four weeks they have had 3 up revisions for the earnings forecast,
for the fiscal quarter ending Dec 2014. The consensus EPS forecast
is $2.28. , following a 52-week high recorded in prior regular
Twitter, Inc. (
) is +0.18 at $34.65, with 311,472 shares traded. TWTR's current
last sale is 82.5% of the target price of $42.
Alcatel Lucent (
) is unchanged at $3.94, with 297,323 shares traded. ALU's current
last sale is 87.56% of the target price of $4.5.
Sprint Corporation (
) is +0.18 at $8.95, with 219,881 shares traded. S's current last
sale is 111.88% of the target price of $8.
Facebook, Inc. (
) is +0.43 at $63.31, with 169,399 shares traded. As reported by
Zacks, the current mean recommendation for FB is in the "buy
Sealed Air Corporation (
) is +0.54 at $33.60, with 113,000 shares traded. SEE's current
last sale is 92.05% of the target price of $36.5.
Francesca's Holdings Corporation (
) is -1.45 at $13.83, with 107,093 shares traded. RTT News Reports:
Francesca Q1 Profit Down, But Revenues Rise - Quick Facts
Receptos, Inc. (
) is +9.18 at $38.38, with 104,248 shares traded. As reported by
Zacks, the current mean recommendation for RCPT is in the "strong
Avanir Pharmaceuticals, Inc. (
) is +0.33 at $5.67, with 102,796 shares traded. As reported by
Zacks, the current mean recommendation for AVNR is in the "buy
Bank of America Corporation (
) is -0.05 at $15.79, with 93,665 shares traded. BAC's current last
sale is 87.72% of the target price of $18.